Navigation Links
Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris
Date:7/9/2008

BIRMINGHAM, Ala., July 9 /PRNewswire/ -- A lawsuit charges pharmaceutical giant Pfizer was motivated by greed when it failed to warn the public of potentially deadly side-effects associated with its popular smoking cessation drug varenicline which is marketed under the trade name Chantix. The suit, brought by the widow of an Indiana man, alleges the decedent committed suicide after using Chantix as prescribed. The victim's tragic death occurred only a few days before the information contained in the drug label and package insert for patients was amended to include warnings for the increased risk of experiencing suicide and similar tragedies. Further, the widow blames Pfizer in the lawsuit by identifying many specific instances of bad conduct, and suggests that Pfizer pursued profit over patient safety.

"This man's death was a direct result of taking the drug Chantix," said Kristian Rasmussen, veteran pharmaceutical litigation attorney with the law firm Cory Watson Crowder & DeGaris. Rasmussen and attorney William E. Winingham of Wilson, Kehoe and Winingham are representing the victim's widow.

The suit says the man was not warned of potentially devastating side effects when he began taking Chantix in October 2007. The man died of a self-inflicted gunshot wound in January, 2008. Less than a month after the Plaintiff committed suicide, Pfizer modified the package insert on Chantix to recommend that all patients being treated with Chantix "be observed for neuropsychiatric symptoms including ... suicidal ideation and suicidal behavior."

"Pfizer's action was too little too late," said Rasmussen. The lawsuit accuses Pfizer of putting profits before patient safety and claims Pfizer failed to report suspected side effects for fear the warnings would cut into sales and profits. Chantix revenues reached $883 million in 2007, according to corporate performance reports available on the company's website. The suit seeks unspecified damages and accuses Pfizer of intentionally, recklessly and or negligently concealing, suppressing, omitting or misrepresenting the risks, dangers, defects and disadvantages of Chantix.

About Cory Watson Crowder & DeGaris

Cory Watson Crowder & DeGaris is recognized nationally for its practice in mass torts litigation, multidistrict litigation and complex litigation including class actions, products liability, business and securities litigation, environmental litigation and mass torts litigation of defective medical devices and pharmaceuticals.


'/>"/>
SOURCE Cory Watson Crowder & DeGaris
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Litigation Predicted in Wake of FAA Ban of Chantix Use by Pilots and Air Traffic Controllers: Smoking Cessation Drug Target of Controversy
2. Road pollution blamed for higher allergy risk in kids
3. People with anorexia less likely to be blamed when biology, genetics explained
4. Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer
5. Antidepressants in suicide prevention
6. As I-1000 Signatures are Counted, Washington State Medical Association Opposition to Physician-Assisted Suicide Reiterated
7. Hope, Volume One, a CD benefiting Suicide Awareness Voices of Education (SAVE), to Be released on June 24, 2008
8. Drink and drugs fuel Scottish suicide and homicide rates
9. Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans
10. Californians Against Assisted Suicide - Controversial Bill, AB 2747 Narrowly Passes Assembly
11. VA Secretary Appoints Panel of National Suicide Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
Breaking Medicine Technology: